Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " April 17, 2013":" May 17, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 17, 2013":" May 17, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois
Condition: HIV Infections
Interventions: Behavioral: Correctional case management;   Behavioral: Transitional case management
2 Enrolling by invitation The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Condition: HIV Infection
Intervention: Other: Self-Collected HPV Test
3 Completed Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection
Condition: HIV
Interventions: Dietary Supplement: Prebiotics+Glutamine;   Dietary Supplement: Placebo
4 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
5 Unknown  Immune Activation and Drug Absorption in HIV-Infected Patients
Condition: HIV Infection
Intervention: Drug: Rifampicin 600 mg
6 Recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
7 Completed Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
Condition: HIV
Intervention: Device: PrePex
8 Completed An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Condition: HIV-associated Lipodystrophy Syndrome
Interventions: Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B;   Drug: 150 mg GSK1265744B;   Drug: Placebo
9 Completed Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome (AIDS)
Intervention: Other: Questionnaire
10 Completed Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV
Condition: HIV
Intervention: Behavioral: Aerobic and Strength Training Intervention
11 Active, not recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: rVSV;   Biological: IL-12 pDNA adjuvant;   Biological: HIV-Mag pDNA;   Drug: Placebo
12 Recruiting Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
Condition: HIV
Interventions: Biological: pSG2.HIVconsv DNA vaccine;   Biological: ChAdV63.HIVconsv booster vaccine;   Biological: MVA.HIVconsv booster vaccine;   Drug: CPHPC;   Other: Placebo
13 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)
14 Completed
Has Results
Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat
Condition: Human Immunodeficiency Virus Type 1 (HIV-1)
Interventions: Drug: Atazanavir;   Drug: Cobicistat;   Drug: Atazanavir/Cobicistat FDC
15 Active, not recruiting Monoclonal Antibody-based Multipurpose Microbicides
Conditions: HIV;   Sexually Transmitted Infections (STI)
Intervention:
16 Active, not recruiting Kumasi Cohort Study
Condition: HIV
Intervention: Other: Virological monitoring
17 Withdrawn Project TEACH-Kenya
Condition: HIV
Intervention: Behavioral: Risk Reduction Intervention
18 Active, not recruiting Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Condition: HIV
Intervention: Drug: Lubiprostone
19 Not yet recruiting Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients
Condition: Severely Immunocompromised HIV Patients
Interventions: Drug: Use of Raltegravir-based regimens;   Drug: Efavirenz-based regimens
20 Completed Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial
Conditions: HIV;   Addiction
Intervention: Other: Integrated methadone and antiretroviral therapy (iMART) clinic

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.